Articles On Telix Pharmaceuticals (ASX:TLX)
| Title | Source | Codes | Date |
|---|---|---|---|
|
ASX Market Moves: Earnings Cheer Meets Global Tension
Highlights Global tensions weigh on market mood Energy shares gain as oil rises Earnings season drives stock moves Australian equities experienced mixed momentum as geopolitical concerns shaped sentiment, while strong... |
Kalkine Media | TLX | 14 hours ago |
|
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) ended its trading week on a sour note this Friday, recording its only loss on what has otherwise been a stellar week for ASX investors. After beginning the day deep in re... |
Motley Fool | TLX | 16 hours ago |
|
Closing Bell: ASX slips on Friday, but oil’s well that ends well for the week
The ASX closed 0.5% lower on Friday but at least it remained up for the week Energy best performing sector on ASX today as oil price rises on Middle East tensions Mixed day of earnings with QBE Insurance and Telix Pharmaceuticals posting s... |
Stockhead | TLX | 16 hours ago |
|
Scott Power: ‘Little rays of sunshine’ in stormy ASX healthcare reporting season
The ASX healthcare sector fell 0.73% this week as reporting season continued Pathology and radiology provider Sonic Healthcare rises with H1 results ahead of expectations Morgans lifts its target price for protective gear maker Ansell afte... |
Stockhead | TLX | 18 hours ago |
|
This biotech says it will turn over more than $1 billion next year. Is it undervalued?
Telix Pharmaceuticals Ltd (ASX: TLX) has reported a huge jump in full year revenues while also saying it expects to easily beat that amount in the current year. The drug company said in a statement to the ASX on Friday that full year re... |
Motley Fool | TLX | 19 hours ago |
|
Why PWR, QBE, Telix, and Zip shares are storming higher today
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down slightly to 9,081.3 points. Four ASX shares that are not letting that hold them back are... |
Motley Fool | TLX | 20 hours ago |
|
Why the ASX 200 Is Gripping the Market’s Most Watched Shorts
highlights Market divergence is reshaping sentiment across key sectors Several well-known names remain under sustained pressure Short positioning reveals where confidence is being tested Short positioning across promin... |
Kalkine Media | TLX | 1 day ago |
|
Prediction: Telix shares could triple in value this year
Telix Pharmaceuticals Ltd (ASX: TLX) shares have crashed over 21% since the start of 2026 after the company's latest Q4 FY25 results disappointed investors. The company reported in late January that it had achieved the lower end of it... |
Motley Fool | TLX | 1 day ago |
|
ASX Rally Gains Momentum as Earnings Drive Market Moves
Highlights Earnings updates steer ASX market direction Superloop leads gains with strong financial turnaround Technology and financial stocks show notable strength The Australian share market ended on a stronger note a... |
Kalkine Media | TLX | 2 days ago |
|
Why are Telix shares trading higher today?
Shares in Telix Pharmaceuticals Ltd (ASX: TLX) were trading higher on Wednesday after the company said it had filed a key regulatory approval in Europe. Telix, in a statement to the ASX, said it had submitted a marketing authorisation a... |
Motley Fool | TLX | 2 days ago |
|
TechnologyOne upgrades earnings guidance on AI and SaaS momentum
The TechnologyOne Ltd (ASX: TNE) share price is in focus today after Australia's largest ERP SaaS company lifted its FY26 profit guidance by 5 percentage points, targeting 18% to 20% profit before tax (PBT) growth and 16% to 18% annual recu... |
Motley Fool | TLX | 2 days ago |
|
These 2 ASX healthcare shares could jump well over 80%
These 2 ASX healthcare shares have had an ordinary start to 2026. Telix Pharmaceuticals Ltd (ASX: TLX) and Neuren Pharmaceuticals Ltd (ASX: NEU) shares have lost 21% and 31% respectively this year so far. However, both ASX healthcare... |
Motley Fool | TLX | 2 days ago |
|
SGH Ltd confirms $32.35 per share BlueScope bid
The SGH Ltd (ASX: SGH) share price is in focus after the company and Steel Dynamics Inc. confirmed a best and final $32.35 per share offer to acquire BlueScope Steel Ltd (ASX: BSL) valuing BlueScope at $15 billion in cash. The proposal repr... |
Motley Fool | TLX | 2 days ago |
|
The Lottery Corporation posts steady earnings and dividend for 1H26
The Lottery Corporation Ltd (ASX: TLC) share price is in focus today after the company revealed a resilient half-year result for the six months ended 31 December 2025, with group revenue up 2% to $1.82 billion and an 8.0 cent per share full... |
Motley Fool | TLX | 2 days ago |
|
Are these ASX shares too cheap to pass up?
Here at The Motley Fool, we are constantly sifting through the noise to find ASX shares that could be undervalued. Of course, not every down-and-out company is a value. But here are three ASX shares that might have fallen too far t... |
Motley Fool | TLX | 2 days ago |
|
Dexus posts $348.5m half-year profit as property values lift
The Dexus (ASX: DXS) share price is in focus as the property group delivered a half-year statutory net profit after tax of $348.5 million, up sharply from $10.3 million a year ago, and declared an interim distribution of 19.3 cents per secu... |
Motley Fool | TLX | 3 days ago |
|
Telix Pharmaceuticals files European application for brain cancer imaging
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus as the company announced it has submitted a European marketing authorisation application for TLX101-Px, its brain cancer imaging agent, aiming to widen access to advanced diag... |
Motley Fool | TLX | 3 days ago |
|
Netwealth earnings: 24% revenue jump and record inflows
The Netwealth Group Ltd (ASX: NWL) share price is in focus today after the wealth platform provider posted a 25% lift in revenue to $193.8 million and record custodial inflows of $16.4 billion for the half. What did Netwealth report? Reven... |
Motley Fool | TLX | 3 days ago |
|
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Feb. 18, 2026 /PRNewswire/ — Telix Pharmac... |
FNArena | TLX | 3 days ago |
|
Suncorp Group posts resilient 1H26 earnings despite higher claims
The Suncorp Group Ltd (ASX: SUN) share price is in focus today after the company reported first-half FY26 net profit after tax (NPAT) of $263 million, as natural hazard claims surged to $1.3 billion but underlying insurance margins and capi... |
Motley Fool | TLX | 3 days ago |
|
National Australia Bank posts strong first quarter FY26 earnings
The National Australia Bank Ltd (ASX: NAB) share price is in focus today after the bank delivered a strong start to FY26, with cash earnings climbing 15% and underlying profit up 12% compared to the prior equivalent period. What did Nationa... |
Motley Fool | TLX | 3 days ago |
|
Ventia extends NZ$160m Transpower contract: What it means for investors
The Ventia Services Group Ltd (ASX: VNT) share price is in focus today after the company extended its specialist electrical services contract with Transpower in New Zealand, an agreement expected to deliver approximately NZ$160 million in r... |
Motley Fool | TLX | 3 days ago |
|
Spark New Zealand earnings: profit rebounds, dividend declared
The Spark New Zealand Ltd (ASX: SPK) share price is in focus today after the company reported a strong half-year result, with EBITDAI up 10.3% to $448 million and net profit rising 82.9% to $64 million. What did Spark New Zealand report? R... |
Motley Fool | TLX | 3 days ago |
|
Mirvac Group posts 5% profit growth, expands pipeline in 1H26
The Mirvac Group (ASX: MGR) share price is in focus today after the company posted a 5% boost in first-half operating profit to $248 million and grew earnings per security to 6.3 cents. What did Mirvac Group report? EBIT of $398 million, u... |
Motley Fool | TLX | 3 days ago |
|
Iluka Resources posts lower FY25 profit but advances rare earths strategy
The Iluka Resources Ltd (ASX: ILU) share price is in focus after the miner posted $976 million in full-year mineral sands revenue and declared a final dividend of 3 cents per share fully franked. What did Iluka Resources report? Mineral sa... |
Motley Fool | TLX | 3 days ago |
|
ASX 200 Watch: Where Market Trends Are Quietly Shifting
Highlights Trend shifts are reshaping attention across select ASX-listed shares Market scans highlight contrasting momentum across sectors Broader sentiment reflects evolving dynamics within the Australian market ASX m... |
Kalkine Media | TLX | 3 days ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 4 days ago |
|
ASX 200 Update: All Ordinaries Shares Slide to Multi-Year Lows
Highlights A cluster of ASX 200 shares traded near multi-year lows. Earnings season created divergence between record highs and sharp pullbacks. Retail, healthcare, technology and property names faced pressure. Several... |
Kalkine Media | TLX | 1 week ago |
|
13 ASX 200 shares hit multi-year lows as the market takes a breather
S&P/ASX 200 Index (ASX: XJO) shares are down 1.3% at 8,925.3 points at the time of writing on Friday. The market is taking a breather after a strong week that saw the ASX 200 lift to a 14-week high of 9,043.5 points. Earnings s... |
Motley Fool | TLX | 1 week ago |
|
Where to invest $10,000 in ASX growth shares
Do you have $10,000 to put into the share market and a penchant for ASX growth shares? If you do, then it could be worth considering the three named in this article that brokers rate as buys. Here's why they could be top picks: Breville Gr... |
Motley Fool | TLX | 1 week ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 1 week ago |
|
Buy, hold, sell: CSL, Pinnacle, and Telix shares
The three ASX shares in this article are popular options for investors. But are they buys, holds, or sells? Let's see what analysts are saying about them right now: CSL Ltd (ASX: CSL) The team at Morgans thinks that this biotech giant's sh... |
Motley Fool | TLX | 2 weeks ago |
|
Rudi’s View: Woolies, CSL, Macquarie (& More)
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Updates on Conviction Calls, Best Buys and most favoured sector picks for the Februa... |
FNArena | TLX | 2 weeks ago |
|
“Your Stock Request” – 5 February 2026
“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o... |
Fairmont Equities | TLX | 2 weeks ago |
|
Telix Full Year Results 2025 Investor Webcast Notification
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Feb. 4, 2026 /PRNewswire/ — Telix Pharmace... |
FNArena | TLX | 2 weeks ago |
|
Will Telix shares drop below $10?
Telix Pharmaceuticals Ltd (ASX: TLX) shares have dropped another 2.81% in Tuesday afternoon trade. At the time of writing, the shares are changing hands at a two-year low of $10.18 a piece. For the year-to-date the shares are now down... |
Motley Fool | TLX | 2 weeks ago |
|
2 ASX shares highly recommended to buy: Experts
When one expert thinks an ASX share is a buy, that's interesting. When numerous analysts think a business is a buy, that could be a clear indication that the business is a potential opportunity. I'm going to talk about a couple of busine... |
Motley Fool | TLX | 2 weeks ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 2 weeks ago |
|
These 2 ASX shares are set to soar in 2026 and beyond
The Australian share market has delivered an average return in the region of 10% per annum over the long term. While this is a great return, Bell Potter thinks these ASX shares could rise materially more in 2026. Here's what it is recommend... |
Motley Fool | TLX | 3 weeks ago |
|
ASX 200 Health Sector Update on Clinical Momentum and Discovery Pathways
Highlights Australian health companies reported progress across diagnostics, therapeutics, and clinical development Research milestones and regulatory updates shaped quarterly activity in the healthcare space ASX-listed heal... |
Kalkine Media | TLX | 3 weeks ago |
|
3 ASX stocks every Aussie investor should consider in 2026
It's been a subdued start to the year for ASX stocks. The S&P/ASX 300 Index (ASX: XKO) is 1.57% higher for the year-to-date, and the S&P/ASX 200 Index (ASX: XJO) is up 1.62% as cost-of-living pressures, cash rate hike concerns and m... |
Motley Fool | TLX | 3 weeks ago |
|
Down 60%, is there a once-in-a-decade opportunity in this ASX 200 stock?
A 60% share price fall in just 12 months is enough to scare off even confident investors. When it happens to a popular ASX 200 stock, it naturally raises a hard question. Is this a value opportunity, or a warning sign? In the case of Tel... |
Motley Fool | TLX | 3 weeks ago |
|
Biocurious: What to expect in a ‘difficult’ profit-reporting season for healthcare stocks
Given the sector’s travails, investors should delve into the February earnings disclosures even more diligently than usual Despite their defensive reputation, healthcare stocks have, on the whole, done poorly post pandemic In most cases, d... |
Stockhead | TLX | 3 weeks ago |
|
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) enjoyed a euphoric start to the short trading week this Tuesday. Investors seemed to come back from the long weekend feeling refreshed and invigorated, if the share mark... |
Motley Fool | TLX | 3 weeks ago |
|
Closing Bell: ASX rips higher as BHP knocks off CBA’s crown
ASX surges 0.92% with nine of 11 sectors higher Strong breadth; 127 stocks rising and just 65 falling Telecoms and materials lead gains with support from banks BHP dethrones Commonwealth Bank A broad surge in metals almost across the bo... |
Stockhead | TLX | 3 weeks ago |
|
ASX 200 Watch: Market Momentum Builds Across Key Sectors
Highlights Materials and energy names continue to dominate market attention Sector-wide momentum reflects shifting demand and capital flows Select ASX 200 companies show renewed strength across key industries Market mo... |
Kalkine Media | TLX | 3 weeks ago |
|
ASX 200 Momentum Watch: Market Signals Behind Fresh Highs and Lows
Highlights Strong momentum continues across key resource-led sectors Market leadership shifts reveal deeper structural trends Volatility highlights changing sentiment across major ASX groups The ASX market shows renewe... |
Kalkine Media | TLX | 3 weeks ago |
|
Weekly Ratings, Targets, Forecast Changes – 23-01-26
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha... |
FNArena | TLX | 3 weeks ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 3 weeks ago |
|
Scott Power: ASX healthcare lifts as focus turns to reporting season
ASX health sector up 0.53% for the week, while broader market rises 0.36% Companies start reporting quarterly results next week ahead of half-year reporting season Third US clinical site approved for Imricor’s VISABL‑AFL trial to support U... |
Stockhead | TLX | 4 weeks ago |